Dawn Mccleverty

Dawn Mccleverty is an experienced professional in the field of pharmaceutical regulatory affairs, currently serving as the Executive Director of CMC Regulatory Affairs at AstraZeneca since 2022. Prior to this role, Dawn held various senior positions at GSK between 2016 and 2019, including Director of Mature Product CMC Regulatory. Dawn began their career at Pfizer, where they worked from 1995 to 2006, advancing from an Analytical Scientist to a Senior Principal Scientist focusing on regulatory CMC for clinical trials and new product development. Dawn earned a degree in analytical science from Dublin City University in 1994.